Levodopa

Overview

Levodopa is a precursor to the neurotransmitter dopamine used to treat Parkinson's disease and dopamine-responsive dystonia. It is often combined with a peripheral decarboxylase inhibitor like carbidopa to increase its effectiveness.

API suppliers (15)

Suppliers of Levodopa evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.

• AJINOMOTO CO INCJapan2 active DMF GMP on record
• SHANDONG XINHUA PHARMACEUTICAL CO LTDChina1 active DMF GMP on record
• MAITHRI DRUGS PRIVATE LTDIndia1 active DMF GMP on record
• Hetero Drugs LimitedIndia1 active DMF GMP on record
• ZHEJIANG YONGTAI CHIRAL MEDICINE TECHNOLOGY CO LTDChina1 active DMF
• MIANYANG SHENGSHI HEALTH TECHNOLOGY CO LTD1 active DMF
• MSN LIFE SCIENCES PRIVATE LIMITEDIndia1 active DMF GMP on record
• Zhejiang Wild Wind Pharmaceutical Co.,Ltd.China1 active DMF
• Zhejiang Huahai Pharmaceutical Co., Ltd.China1 active DMF GMP on record
• Acella Pharmaceuticals, LLCUnited States1 active DMF
• Divis LaboratoriesIndia1 active DMF GMP on record
• KEY PHARMACEUTICALS INC SUB SCHERING PLOUGH CORP
• PFC ITALIANA SRL DIV ALFA CHEMICALS ITALIANA
• Torrent PharmaceuticalsIndia GMP on record
• EGIS PHARMACEUTICALS PRIVATE LTD GMP on record

Patent & exclusivity (US)

Per the FDA Orange Book (1 approved US product), the latest listed US patent on Levodopa expires 21 Oct 2033. Generic API sourcing typically opens up once these lapse.

Therapeutic areas